A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to see if better control of type 2 diabetes can occur in patients taking a stable dose of metformin when they are also provided either sitagliptin or glimepiride. This study will also see if this treatment is safe and tolerable.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Glimepiride; Metformin; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• 18 years or older

• Diagnosed with type 2 diabetes

• On a stable dose of metformin of at least 1500 mg per day

Exclusion Criteria:

• History of type 1 diabetes

• Pregnant

• HIV positive

• On a weight loss program or medication

• Has a history of blood disorder, certain cancers, heart, liver or kidney disease